HK81497A - Heterocyclic sulphonamide leukotriene antagonist - Google Patents

Heterocyclic sulphonamide leukotriene antagonist

Info

Publication number
HK81497A
HK81497A HK81497A HK81497A HK81497A HK 81497 A HK81497 A HK 81497A HK 81497 A HK81497 A HK 81497A HK 81497 A HK81497 A HK 81497A HK 81497 A HK81497 A HK 81497A
Authority
HK
Hong Kong
Prior art keywords
leukotriene antagonist
sulphonamide
heterocyclic
heterocyclic sulphonamide
leukotriene
Prior art date
Application number
HK81497A
Other languages
English (en)
Inventor
Martin Paul Edwards
John David Sherwood
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of HK81497A publication Critical patent/HK81497A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK81497A 1990-12-12 1997-06-19 Heterocyclic sulphonamide leukotriene antagonist HK81497A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909027018A GB9027018D0 (en) 1990-12-12 1990-12-12 Heterocyclic compounds

Publications (1)

Publication Number Publication Date
HK81497A true HK81497A (en) 1997-06-27

Family

ID=10686919

Family Applications (1)

Application Number Title Priority Date Filing Date
HK81497A HK81497A (en) 1990-12-12 1997-06-19 Heterocyclic sulphonamide leukotriene antagonist

Country Status (28)

Country Link
US (1) US5294636A (fr)
EP (1) EP0490649B1 (fr)
JP (1) JP2650807B2 (fr)
KR (1) KR100194479B1 (fr)
CN (2) CN1032469C (fr)
AP (1) AP286A (fr)
AT (1) ATE145199T1 (fr)
AU (1) AU656344B2 (fr)
CA (1) CA2056067C (fr)
CZ (1) CZ288151B6 (fr)
DE (1) DE69123123T2 (fr)
DK (1) DK0490649T3 (fr)
ES (1) ES2094797T3 (fr)
FI (1) FI101296B1 (fr)
GB (2) GB9027018D0 (fr)
GR (1) GR3021605T3 (fr)
HK (1) HK81497A (fr)
HU (2) HU213109B (fr)
IE (1) IE914316A1 (fr)
IL (1) IL100090A (fr)
MX (1) MX9102475A (fr)
MY (1) MY108629A (fr)
NZ (1) NZ240940A (fr)
PH (1) PH30041A (fr)
RU (1) RU2107682C1 (fr)
SK (1) SK279018B6 (fr)
TW (1) TW222264B (fr)
ZA (1) ZA919772B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2063479T3 (es) * 1990-05-04 1995-01-01 Ciba Geigy Ag Indoles substituidos.
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)
GB9119001D0 (en) * 1991-09-05 1991-10-23 Ici Plc Pharmaceutical agents
GR1001368B (el) * 1992-10-08 1993-10-29 Ici Plc Φαρμακευτικοί φορείς.
DE4235133A1 (de) * 1992-10-19 1994-04-21 Bayer Ag Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid
EG20677A (en) * 1993-10-01 1999-11-30 Astra Ag Method and an apparatus for micronizing the particle size
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
GB9723985D0 (en) * 1997-11-14 1998-01-14 Zeneca Ltd Pharmaceutical compositions
GB9726735D0 (en) * 1997-12-18 1998-02-18 Zeneca Ltd Pharmaceutical compositions
IL139243A0 (en) * 2000-10-24 2001-11-25 Internat Specialty Products Is Ethanolate of zafirlukast, process for manufacture and pharmaceutical compositions thereof
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
US20050026882A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20090317476A1 (en) * 2003-07-31 2009-12-24 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
JP2008531721A (ja) * 2005-03-03 2008-08-14 エラン・ファルマ・インターナショナル・リミテッド 複素環式アミド誘導体のナノ粒子状組成物
US20070197467A1 (en) * 2006-02-06 2007-08-23 Srinivasulu Rangineni Zafirlukast compositions
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
CN101835749A (zh) * 2007-07-30 2010-09-15 奥斯拜客斯制药有限公司 取代的吲哚
TWI469965B (zh) * 2008-12-22 2015-01-21 Ono Pharmaceutical Co 乙炔基吲哚化合物
WO2014012954A1 (fr) 2012-07-18 2014-01-23 Takeda Gmbh Traitement de l'asthme sévère partiellement régulé ou non régulé
CN103396353B (zh) * 2013-08-23 2015-05-20 海南通用三洋药业有限公司 一种扎鲁司特无定型态及其制备方法
CA2936332A1 (fr) 2014-01-22 2015-07-30 Takeda Gmbh Traitement de l'asthme grave partiellement controle ou non controle avec un inhibiteur de pde4 (et en combinaison avec un modificateur des leucotrienes)
PT109030B (pt) * 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. Preparação de partículas inaláveis de zafirlucaste
EP3585809A4 (fr) 2017-01-30 2021-02-24 Western New England University Inhibiteurs de thiol isomérases et leur utilisation
US20220370401A1 (en) 2021-05-19 2022-11-24 Quercis Pharma AG Method for treating amyotrophic lateral sclerosis using quercetin-containing compositions
WO2023214391A1 (fr) 2022-05-06 2023-11-09 Quercis Pharma AG Méthode de traitement de cancers et de maladies neurologiques à l'aide de compositions contenant de la quercétine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives

Also Published As

Publication number Publication date
ATE145199T1 (de) 1996-11-15
DE69123123T2 (de) 1997-03-06
HU211125A9 (en) 1995-10-30
AP286A (en) 1993-09-26
GB2250743A (en) 1992-06-17
ZA919772B (en) 1992-09-30
CN1063100A (zh) 1992-07-29
CN1032469C (zh) 1996-08-07
GB2250743B (en) 1995-02-15
FI915825A0 (fi) 1991-12-11
NZ240940A (en) 1994-05-26
JP2650807B2 (ja) 1997-09-10
CZ288151B6 (en) 2001-05-16
IL100090A (en) 1996-09-12
SK279018B6 (sk) 1998-05-06
FI101296B (fi) 1998-05-29
DK0490649T3 (da) 1997-04-21
ES2094797T3 (es) 1997-02-01
MY108629A (en) 1996-10-31
EP0490649B1 (fr) 1996-11-13
MX9102475A (es) 1992-06-01
CA2056067C (fr) 2001-09-04
GR3021605T3 (en) 1997-02-28
HUT60717A (en) 1992-10-28
AP9100341A0 (en) 1992-01-31
AU8899591A (en) 1992-06-18
EP0490649A1 (fr) 1992-06-17
JPH04266872A (ja) 1992-09-22
PH30041A (en) 1996-11-08
RU2107682C1 (ru) 1998-03-27
AU656344B2 (en) 1995-02-02
CN1074411C (zh) 2001-11-07
HU913863D0 (en) 1992-02-28
FI101296B1 (fi) 1998-05-29
KR100194479B1 (ko) 1999-06-15
KR920012031A (ko) 1992-07-25
GB9027018D0 (en) 1991-01-30
FI915825A (fi) 1992-06-13
CS375891A3 (en) 1992-06-17
TW222264B (fr) 1994-04-11
CA2056067A1 (fr) 1992-06-13
IE914316A1 (en) 1992-06-17
CN1148491A (zh) 1997-04-30
DE69123123D1 (de) 1996-12-19
US5294636A (en) 1994-03-15
IL100090A0 (en) 1992-08-18
GB9126353D0 (en) 1992-02-12
HU213109B (en) 1997-02-28

Similar Documents

Publication Publication Date Title
GB2250743B (en) Heterocyclic sulphonamide leukotriene antagonist
PH27573A (en) New heterocyclic derivatives
ZA913512B (en) Heterocyclic compounds
ZA911111B (en) Leukotriene antagonists
GB9127279D0 (en) Heterocyclic derivatives
GB9225283D0 (en) Heterocyclic derivatives
IL100483A0 (en) Sulphonamide derivatives
GB9102804D0 (en) Heterocyclic derivatives
GB9201789D0 (en) Heterocyclic derivatives
GB9020932D0 (en) Heterocyclic compounds
HU9203971D0 (en) Sulphonamide derivatives
GB9204464D0 (en) New heterocyclic derivatives
GB9202633D0 (en) Heterocyclic derivatives
GB9015486D0 (en) Heterocyclic derivatives
ZA917228B (en) Heterocyclic derivatives
IE900817L (en) Tetrahydroquinoline derivatives
ZA91580B (en) Heterocyclic compounds
ZW891A1 (en) Heterocyclic compounds
GB9022112D0 (en) Heterocyclic compounds
GB9008821D0 (en) Heterocyclic compounds
GB9003556D0 (en) Heterocyclic compounds
ZA913604B (en) Heterocyclic-nmda antagonists
ZA92127B (en) Sulphonamide derivatives
ZA914382B (en) Substituted phthalides and heterocyclic phthalides
GB9106956D0 (en) Heterocyclic derivatives

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20051211